Bristol Myers Flags Data-Rich 2026 After Solid Quarter

Bristol Myers Squibb & Co. (NYSE:BMY) reported fourth-quarter 2025 revenues of $12.50 billion on Thursday, beating the consensus of $12.281 billion, a 1% increase year over year."We made significant progress in 2025, with real momentum in our Growth Portfolio and a strengthened balance sheet that provides the strategic flexibility to continue investing in growth drivers," said Christopher Boerner, board chair and CEO, Bristol Myers Squibb."2026 is data-rich, and we are advancing a truly differentiated pipel ...